{"url_path":"/sec/goco/8-k/2026-07-21/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/1808220/0001628280-26-049063-index.html","accession_number":"0001628280-26-049063","cik":"0001808220","ticker":"GOCO","issuer_name":"GoHealth, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1808220/0001628280-26-049063-index.html","primary_entity_key":"0001808220","primary_entity_name":"GoHealth, Inc."},"word_count":136,"has_tables":true,"body_markdown":"Item 7.01 Regulation FD Disclosure.\n\n \n\nOn July 21, 2026, the Company issued a press release in connection with the effectiveness of the Plan. A copy of the press release is furnished in this Current Report as Exhibit 99.2 and is incorporated herein by reference.\n\nThe information contained in this Item 7.01 shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing."}